Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) has released its Q2 earnings. Here is a breakdown of the information Guardian Pharmacy Services, Inc. Class A presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Guardian Pharmacy Services, Inc. is a leading provider of long-term care pharmacy services, partnering with facilities to deliver medications and technology-enabled services across 38 states. The company reported strong financial results for the second quarter of 2025, with a 15% increase in revenue to $344.3 million, driven by organic growth and recent acquisitions. Despite a decrease in net income to $8.8 million due to tax and compensation expenses, the adjusted EBITDA rose to $25.0 million. The company also expanded its presence with new pharmacies in Kansas, Washington, and Florida, and completed a secondary offering to enhance liquidity. Looking ahead, Guardian Pharmacy Services has raised its full-year guidance for revenue and adjusted EBITDA, reflecting confidence in its growth strategy and market position.